NCT00041652View on ClinicalTrials.gov

Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

June 30, 2003

Conditions
Colorectal CancerColon CancerRectal CancerColorectal NeoplasmsColorectal CarcinomaBreast CancerBreast Neoplasms
Interventions
DRUG

hMN14 (labetuzumab)

Trial Locations (1)

92658

Hoag Cancer Center, Newport Beach

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY